Determinants of Antiretroviral Treatment Success and Adherence in People With Human Immunodeficiency Virus Treated for Tuberculosis

BACKGROUND: In people with human immunodeficiency virus [HIV] presenting with advanced disease, rates of virologic success may be lower than expected. The Reflate TB2 trial did not show non-inferiority of raltegravir versus efavirenz in people with HIV (PWH) treated for tuberculosis. We aimed to ide...

Descripción completa

Detalles Bibliográficos
Autores principales: De Castro, Nathalie, Chazallon, Corine, N'takpe, Jean-Baptiste, Timana, Isabel, Escada, Rodrigo, Wagner, Sandra, Messou, Eugène, Eholie, Serge, Bhatt, Nilesh, Khosa, Celso, Laureillard, Didier, Do Chau, Giang, Veloso, Valdilea G, Delaugerre, Constance, Anglaret, Xavier, Molina, Jean-Michel, Grinsztejn, Beatriz, Marcy, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9757687/
https://www.ncbi.nlm.nih.gov/pubmed/36540390
http://dx.doi.org/10.1093/ofid/ofac628

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9757687/
https://www.ncbi.nlm.nih.gov/pubmed/36540390
http://dx.doi.org/10.1093/ofid/ofac628

Ejemplares similares